Related references
Note: Only part of the references are listed.A DNA hypermethylation module for the stem/progenitor cell signature of cancer
Hariharan Easwaran et al.
GENOME RESEARCH (2012)
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
Charles M. Rudin et al.
NATURE GENETICS (2012)
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Martin Peifer et al.
NATURE GENETICS (2012)
The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse
Janan T. Eppig et al.
NUCLEIC ACIDS RESEARCH (2012)
Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1
Lauren Averett Byers et al.
CANCER DISCOVERY (2012)
Genetic Disruption of KEAP1/CUL3 E3 Ubiquitin Ligase Complex Components is a Key Mechanism of NF-KappaB Pathway Activation in Lung Cancer
Kelsie L. Thu et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
New driver mutations in non-small-cell lung cancer
William Pao et al.
LANCET ONCOLOGY (2011)
Breast Cancer Methylomes Establish an Epigenomic Foundation for Metastasis
Fang Fang et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis
Pan Du et al.
BMC BIOINFORMATICS (2010)
A sequence-based approach to identify reference genes for gene expression analysis
Raj Chari et al.
BMC MEDICAL GENOMICS (2010)
Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo
Sha Hu et al.
CANCER BIOLOGY & THERAPY (2010)
Integrative Genomic Analyses Identify BRF2 as a Novel Lineage-Specific Oncogene in Lung Squamous Cell Carcinoma
William W. Lockwood et al.
PLOS MEDICINE (2010)
Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns
Karolina Holm et al.
BREAST CANCER RESEARCH (2010)
Genome-wide DNA methylation profiling using Infinium (R) assay
Marina Bibikova et al.
EPIGENOMICS (2009)
lumi:: a pipeline for processing Illumina microarray
Pan Du et al.
BIOINFORMATICS (2008)
Genetic changes in small cell lung carcinoma
Edurne Arriola et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2008)
Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy
Jeeyun Lee et al.
CLINICAL CANCER RESEARCH (2008)
The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma
Motoko Sasaki et al.
LABORATORY INVESTIGATION (2008)
Genomewide Analysis of PRC1 and PRC2 Occupancy Identifies Two Classes of Bivalent Domains
Manching Ku et al.
PLOS GENETICS (2008)
A polycomb repression signature in metastatic prostate cancer predicts cancer outcome
Jindan Yu et al.
CANCER RESEARCH (2007)
Limited-stage small-cell lung cancer: The current status of combined-modality therapy
Mark A. Socinski et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Small cell lung cancer: Have we made any progress over the last 25 years?
Brian E. Lally et al.
ONCOLOGIST (2007)
Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion
P. C. Ma et al.
BRITISH JOURNAL OF CANCER (2007)
Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin
Yangchao Chen et al.
HEPATOLOGY (2007)
EZH2 promotes proliferation and invasiveness of prostate cancer cells
R. J. Bryant et al.
PROSTATE (2007)
Notch-1 regulates pulmonary neuroendocrine cell differentiation in cell lines and in transgenic mice
Lin Shan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer
Yeshayahu Schlesinger et al.
NATURE GENETICS (2007)
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing
Joyce E. Ohm et al.
NATURE GENETICS (2007)
Identification of novel lung genes in bronchial epithelium by serial analysis of gene expression
Kim M. Lonergan et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)
Nuclear overexpression of the E2F3 transcription factor in human lung cancer
Colin S. Cooper et al.
LUNG CANCER (2006)
Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer
B. P. Coe et al.
BRITISH JOURNAL OF CANCER (2006)
Hedgehog signaling in small-cell lung cancer:: Frequent in vivo but a rare event in vitro
Janni Vestergaard et al.
LUNG CANCER (2006)
From genetics to epigenetics:: the tale of Polycomb group and trithorax group genes
Charlotte Grimaud et al.
CHROMOSOME RESEARCH (2006)
The polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion
LM Kamminga et al.
BLOOD (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Role of cell-cycle regulators in lung cancer
M Caputi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Increased expression of EZH2, a polycomb group protein, in bladder carcinoma
S Arisan et al.
UROLOGIA INTERNATIONALIS (2005)
Two prognostically significant subtypes of high-grade lung neuroendocrine turnours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles
MH Jones et al.
LANCET (2004)
Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins
RD Ramirez et al.
CANCER RESEARCH (2004)
The role of new targeted therapies in small-cell lung cancer
A Rossi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis
RHJ Breuer et al.
NEOPLASIA (2004)
Small cell lung cancer in Norway. Should more patients have been offered surgical therapy?
H Rostad et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2004)
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
AP Bracken et al.
EMBO JOURNAL (2003)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Treatment of lung cancer in elderly part II: small cell lung cancer
M Weinmann et al.
LUNG CANCER (2003)
Molecular and cellular biology of small cell lung cancer
M Sattler et al.
SEMINARS IN ONCOLOGY (2003)
Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors
JR Pollack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Suppression of the p53-or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry
M Lomazzi et al.
NATURE GENETICS (2002)
Share Paper
